Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 2:50 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1609–1632 of 6,923 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Stimulation Clear all

Conditions: Pain, Neuropathic, Failed Back Surgery Syndrome
Interventions: Coordinated Reset spinal cord stimulation; Device
Lead sponsor: Stanford University; Other
Eligibility: 22 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Stanford, California

Conditions: Meniscus Tear
Interventions: Transcutaneous Electrical Nerve Stimulation; Other
Lead sponsor: Creighton University; Other
Eligibility: 15 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Neuromuscular Inhibition
Interventions: 1 cm, 5 cm; Procedure
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Hearing Loss, Sensorineural
Interventions: Standard Electrical Categorical Loudness Scaling task (Standard-ELS), Fast Electrical Categorical Loudness Scaling task (Fast-ELS); Device
Lead sponsor: Cochlear; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Lone Tree, Colorado

Conditions: Opioid-use Disorder, Opioid Withdrawal
Interventions: Sparrow Ascent Therapy System, Lofexidine, Extended-release injectable naltrexone; Device · Drug
Lead sponsor: Spark Biomedical, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 4
States / cities: Rancho Mirage, California • Crownsville, Maryland • Center City, Minnesota + 1 more

Conditions: Parkinson Disease, Dystonia
Interventions: Summit RC+S for Motor, 8-week pilot trial of Closed-loop vs. Open-loop Stimulation, Summit RC+S for Sleep; Device · Diagnostic Test
Lead sponsor: University of California, San Francisco; Other
Eligibility: 21 Years to 75 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2028
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: filgrastim, cyclophosphamide, melphalan, peripheral blood stem cell transplantation, low-LET cobalt-60 gamma ray therapy, low-LET photon therapy; Biological · Drug · Procedure + 1 more
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1993 – 2001
U.S. locations: 2
States / cities: Jacksonville, Florida • Rochester, Minnesota

Conditions: Anterior Cruciate Ligament Injury
Interventions: Electrical Stimulation, Eccentric Exercise; Device · Other
Lead sponsor: University of Michigan; Other
Eligibility: 14 Years to 35 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Diffuse Large B-cell Lymphoma
Interventions: Polatuzumab vedotin (PV), Rituximab, Hyaluronidase, Gemcitabine, Cisplatin, Dexamethasone, GCSF; Drug
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Treatment Resistant Depression (TRD), Major Depressive Disorder (MDD)
Interventions: Spaced Transcranial Direct Current Stimulation (tDCS), Sham Spaced tDCS; Device
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 70 Years
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: San Diego, California

Conditions: Breast Neoplasms, Neoplasm Metastasis
Interventions: IL-3; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: Not listed
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1991 – 2001
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Depressive Disorder, Treatment-Resistant
Interventions: tDCS; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 65 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Pain
Interventions: St. Jude Medical Spinal Cord Stimulation Systems; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 614 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 31
States / cities: Scottsdale, Arizona • Azusa, California • Chula Vista, California + 28 more

Conditions: Migraine
Interventions: Cefaly® Abortive Program device; Device
Lead sponsor: Cefaly Technology; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Metastatic Melanoma
Interventions: Ipilimumab, GM-CSF; Drug
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Pain, Intractable, Pain, Chronic
Interventions: Commercially available neurostimulation systems; Device
Lead sponsor: MedtronicNeuro; Industry
Eligibility: 18 Years and older
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 10
States / cities: Carlsbad, California • Fort Myers, Florida • Edina, Minnesota + 7 more

Conditions: Knee Osteoarthritis, Pain, Postoperative, Acupuncture
Interventions: Acupuncture, Peripheral Nerve Stimulator; Other · Device
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years to 70 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Sub-acute and Chronic Low Back Pain
Interventions: trigger point dry needling, Electrical Stimulation; Device
Lead sponsor: William Beaumont Army Medical Center; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: El Paso, Texas

Conditions: Chronic Wound, Diabetes, Spinal Cord Injury, Ischemic Wound
Interventions: exciflex; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2029
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Smoking
Interventions: Repetitive Transcranial Magnetic Stimulation (rTMS); Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 21 Years to 60 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Misophonia
Interventions: Transcranial Magnetic Stimulation (TMS); Other
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 55 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Ovarian Cancer, Testicular Germ Cell Tumor
Interventions: filgrastim, cisplatin, ifosfamide, paclitaxel; Biological · Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 15 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1994 – 2003
U.S. locations: 1
States / cities: New York, New York

Conditions: Schizophrenia
Interventions: repetitive transcranial magnetic stimulation (rTMS), sham stimulation; Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2005
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Persistent Post Traumatic Headache
Interventions: Non-Invasive Vagus Nerve Stimulation, Cannabidiol, Standard of Care; Device · Drug
Lead sponsor: American Society of Pain and Neuroscience, Inc.; Other
Eligibility: 18 Years to 75 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 8
States / cities: Scottsdale, Arizona • Los Angeles, California • Washington D.C., District of Columbia + 5 more

Search by objective public record fields.

Coordinated Reset Spinal Cord Stimulation

Motor and Sensory Deficits Following Partial Meniscectomy

Comparison of Perineural Catheter Depth for the Continuous Popliteal Nerve Block Using Ultrasound Guidance and Dermabond

Investigating Electrical Categorical Loudness Scaling Using a Mobile Research App in Experienced Adult Cochlear Implant Participants

Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder

The Motor Network in Parkinson's Disease and Dystonia: Mechanisms of Therapy

High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse

Electrical Stimulation and Eccentric Exercise for Anterior Cruciate Ligament (ACL) Injury

Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma

Home-Based Randomized Trial of Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression

Phase I Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Plus GM-CSF (Granulocyte-Macrophage Colony Stimulating Factor) Plus Dose Escalation of IL-3 (Interleukin-3) in Metastatic Breast Cancer

Adaptive tDCS for Treatment-Resistant MDD

A Prospective Clinical Outcomes Registry

Abortive Treatment of Migraine With the Cefaly® Abortive Program Device

A Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma Patients

Study to Evaluate Neuromodulation Subject Experience With Contemporary Spinal Cord Stimulation (SCS) Modalities for Chronic Pain

Acupuncture for Low-Dose Opioid for TKA Replacement

Trigger Point Dry Needling vs Trigger Point Dry Needling With Intramuscular Electrical Stimulation

Exciflex Electroceutical Banadage for Chronic Wound Therapy

Bayesian Neurobehavioral Phenotyping: From Mechanism Identification to Personalized Neuromodulation Treatments. R61 PHASE

Transcranial Magnetic Stimulation in Misophonia

Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin

Repetitive Transcranial Magnetic Stimulation for "Voices"

nVNS, CBD, and SoC for Persistent Post-Traumatic Headache